Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AstraZeneca plc (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AZN
Nasdaq
2834
https://www.astrazeneca.com/Home
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AstraZeneca plc (ADR)
Cancer treatments may benefit from lessons of pandemic set-backs -AstraZeneca executive
- May 26th, 2022 4:33 pm
Top Research Reports for Johnson & Johnson, Walt Disney & NextEra Energy
- May 25th, 2022 7:51 pm
AstraZeneca (AZN) Gets EU Nod for COVID-19 Booster Shot
- May 24th, 2022 6:48 pm
FOCUS-U.S. Task Force to consider routine kidney disease screening as new drugs available
- May 23rd, 2022 8:44 pm
Indian vaccine giant Serum plans African plant in global expansion
- May 23rd, 2022 5:56 pm
RPT-FOCUS-U.S. Task Force to consider routine kidney disease screening
- May 23rd, 2022 2:47 pm
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share
- May 23rd, 2022 2:04 pm
European Regulator Approves AstraZeneca's COVID-19 shot As Booster
- May 23rd, 2022 11:26 am
FOCUS-U.S. Task Force to consider routine kidney disease screening
- May 23rd, 2022 11:00 am
AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022
- May 23rd, 2022 11:00 am
AstraZeneca’s Covid-19 vaccine gets EU approval for third doses
- May 23rd, 2022 7:33 am
UPDATE 1-AstraZeneca says EU regulator approves COVID shot as booster
- May 23rd, 2022 6:51 am
Pharma Stock Roundup: FDA Nod to PFE COVID Jab for Age 5-11 & LLY's Tirzepatide
- May 20th, 2022 12:50 pm
Antibiotic resistance efforts get a boost as CARB-X gets $370M
- May 19th, 2022 6:47 pm
UPDATE 1-EU health regulator backs using AstraZeneca COVID shot as booster
- May 19th, 2022 3:37 pm
Merck (MRK) Outperforms Industry This Year So Far: Here's Why
- May 19th, 2022 12:31 pm
5 Stocks to Buy for the Coming Recession
- May 18th, 2022 10:00 pm
AstraZeneca (AZN) Inks Deal to Develop COVID-19 Antibodies
- May 18th, 2022 7:05 pm
From storage to transport, hurdles to getting COVID vaccine to N.Koreans
- May 18th, 2022 6:56 am
AstraZeneca In-Licenses New Suite Of COVID-19 Antibody Candidate(s)
- May 17th, 2022 7:50 pm
Scroll